Home » Topics » BioWorld Science

BioWorld Science
RSS

AEG-1 as a promising new therapeutic target in Parkinson's disease

Nov. 15, 2018

MYK-581 leads to contractile regulation with improved compliance and functional reserve in HCM model

Nov. 15, 2018

KemPharm adds drug for stimulant use disorder to pipeline

Nov. 15, 2018

AsclepiX obtains funds to advance AXT-107

Nov. 15, 2018

Efflux pumps protect against more than antibiotics

Nov. 15, 2018

How failing hearts try to save themselves

Nov. 15, 2018

How resistant bacteria lock in their gains

Nov. 15, 2018

FDA approves Oralair to treat grass pollen-induced allergic rhinitis in pediatric patients

Nov. 14, 2018

United Neuroscience presents preclinical data on Parkinson's disease vaccine candidate UB-312

Nov. 14, 2018

Calliditas begins phase III study of Nefecon in IgA nephropathy

Nov. 14, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...